In this study, the tumour cellularity was enriched by microdissection, and using allelic-specific oligonucleotide hybridisation, they failed to confirm K-Ras oncogenic activation as a significant marker of poor prognosis after surgery for NSCLC. This evidence concerns the gene KRAS and neoplasm.